Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 · Urology · 1,074 citations
https://doi.org/10.1016/j.urology.2005.07.062
L
Liang Cheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.8K
Papers
53.9K
Citations
109
h-index
887
i10-index
Liang Cheng is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Bladder and Urothelial Cancer Treatments & Renal cell carcinoma treatment. The author has an h-index of 109, co-authored 1495 publications.
ORCID: 0000-0001-6049-5293Papers by this author
worksTesticular cancer
2018 · Nature Reviews Disease Primers · 446 citations
https://doi.org/10.1038/s41572-018-0029-0
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
2010 · Human Pathology · 300 citations
https://doi.org/10.1016/j.humpath.2010.02.011
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
2020 · Cells · 243 citations
https://doi.org/10.3390/cells9122653
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
2019 · Nature Communications · 221 citations
https://doi.org/10.1038/s41467-019-09784-9
The 2020 China report of the Lancet Countdown on health and climate change
2020 · The Lancet Public Health · 214 citations
https://doi.org/10.1016/s2468-2667(20)30256-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat